Robert Soiffer
Vice Chair, Department of Medical Oncology · Mass General Brigham
Credentials: · · · ·
History
- Present
Department of Medical Oncology · Mass General Brigham
- Present
Division of Hematologic Malignancies · Mass General Brigham
- Present
Clinical Programs Division · Mass General Brigham
- 1979–1983
Research
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · Last of 18 authors · 929 citations
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Blood · 2014 · 858 citations
Proceedings of the National Academy of Sciences of the United States of America · 2003 · 788 citations
240 papers
223 papers
203 papers · 3 as a fellow
194 papers
193 papers · 2 as a fellow
150 papers · 10 as a fellow
90 papers · 2 as a fellow
68 papers
Grants
- 2019–2025
Immune Modulation After Allogeneic HCT
National Cancer Institute · P01
Contact PI · $13.8M · Dana-Farber Cancer Inst
- 2013–2019
Manipulation of Immune Responsiveness After Hematopoietic Cell Transplantation
National Cancer Institute · R01
Contact PI · $3.7M · Dana-Farber Cancer Inst
- 2013–2019
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
National Cancer Institute · R01
PI · $2.5M · Dana-Farber Cancer Inst
- 1990–2011
Immune Modulation/Hematopoietic Cell Transplantation
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $9M · Dana-Farber Cancer Inst
Clinical trials
- 2005–2013
Principal investigator · Completed · Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
- 2026–2030
Ivosidenib as Post-HSCT Maintenance for AML
Site PI · Recruiting · Phase 2
Massachusetts General Hospital